12/18/2012

Metabolix expects next year to produce pilot-scale Mirel PHA biopolymer resins, then scale to commercial output. The polyhydroxyalkanoates line will be produced in a partnership with Antibióticos.

Full Story:
PlasticsToday.com

Related Summaries